Response assessment in metastatic melanoma treated with ipilimumab and bevacizumab: CT tumor size and density as markers for response and outcome

BACKGROUND: Investigate the tumor diameter and density changes in advanced melanoma patients treated with ipilimumab plus bevacizumab, compare response rates based on different response criteria, and study association between these measures and survival. METHODS: Twenty-one advanced melanoma patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishino, Mizuki, Giobbie-Hurder, Anita, Ramaiya, Nikhil H, Hodi, F Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236430/
https://www.ncbi.nlm.nih.gov/pubmed/25411640
http://dx.doi.org/10.1186/s40425-014-0040-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236430/
https://www.ncbi.nlm.nih.gov/pubmed/25411640
http://dx.doi.org/10.1186/s40425-014-0040-2

Ejemplares similares